Health ❯ Pharmaceuticals

Diabetes

Medications GLP-1 Drugs Type 2 Diabetes Ozempic Drug Pricing Obesity Clinical Trials Anti-obesity Drugs Semaglutide Drug Regulation

Canada Approves First Generic Ozempic, Clearing Dr. Reddy’s Semaglutide

The decision sets up generic competition that could ease costs for patients who now pay hundreds of dollars a month.

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

Biocon Targets One in Five Insulin Users as It Pushes for Global Lead

Lupin Strikes Semaglutide Licensing Deal With Galenicum Covering 23 Countries

Novo Nordisk Launches Ozempic in India With Weekly Starting Price of ₹2,200

Mounjaro Becomes India’s Top-Selling Drug by Value in October

Mounjaro Climbs to No. 2 in India by Sales as Wales Maps NHS Path for Weight‑Loss Drugs

Mounjaro Rivals Trulicity in Cardiovascular Safety and Lowers All-Cause Mortality

B.C. Restricts Sales of Mounjaro and Trulicity to Safeguard Diabetic Supply

Biocon Secures CDSCO Approval for Generic Liraglutide

Study Investigates Vision Loss in Patients Using Popular Diabetes and Weight Loss Drugs

Eli Lilly Announces $3 Billion Wisconsin Manufacturing Expansion

Celebrities and Controversy: The Ozempic Weight Loss Debate

Model Lottie Moss Hospitalized After Misusing Ozempic for Weight Loss